Clinical trial
S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder…
NCT00003824 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00003824 |
|---|---|
| Title | S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer |
| Official title | The Effect of Fluoroquinolones on the Disease-Free Interval in Patients With Stage Ta Transitional Cell Carcinoma of the Bladder |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cephalexin, surgical procedure, Ciprofloxacin |
| Enrollment | 114 |
| Start date | Apr 1, 1999 |
| Primary completion | Jul 1, 2001 |
| Completion | Jan 1, 2007 |
| First posted | Apr 14, 2004 |
| Last update posted | Mar 9, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: